A program to support HIV prevention medicine use among women at risk of HIV
Tests a behavioral program to increase PrEP use in women at risk of HIV.
Plain-language title generated from the registry record
Registry title: SEPA+PrEP-Women Pilot Trial for HIV Prevention Among Women at Risk for HIV
Key facts
- Where
- Coral Gables, United StatesSee the site
Where in United States
- University of Miami School of Nursing and Health StudiesCoral Gables, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Miami
- Trial code
- NCT07864766
- Record updated
- 13 October 2026
- Original description
The purpose of this randomized pilot trial is to evaluate the preliminary efficacy of SEPA+PrEP-Women (Salud/Health, Educación/Education, Prevención/Prevention, Autocuidado/Self-Care plus Pre-Exposure Prophylaxis [PrEP]). The study will assess whether women assigned to SEPA+PrEP-Women demonstrate higher PrEP uptake than controls and will generate initial effect size estimates to inform a future definitive trial.Read full original descriptionShow less
Pilot Testing the Efficacy and Implementation of SEPA+PrEP-Women Intervention for Women at Risk of HIV
The purpose of this randomized pilot trial is to evaluate the preliminary efficacy of SEPA+PrEP-Women (Salud/Health, Educación/Education, Prevención/Prevention, Autocuidado/Self-Care plus Pre-Exposure Prophylaxis [PrEP]). The study will assess whether women assigned to SEPA+PrEP-Women demonstrate higher PrEP uptake than controls and will generate initial effect size estimates to inform a future definitive trial.
Inclusion: Self-identify as a woman; Age 18 years or older; HIV-negative or unknown HIV status; Report vaginal or anal sex with a male partner within the past 6 months; Report at least one HIV risk factor; Not currently using PrEP; Able to provide informed consent.
Exclusion: Currently using PrEP; Does not meet the applicable inclusion criteria; Unable to provide informed consent.